Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 272 | 218 | 410 | 331 | 347 |
| Cost of Goods | 148 | 171 | 182 | 158 | 157 |
| Gross Profit | 124 | 47 | 228 | 173 | 189 |
| Operating Expenses | 5,611 | 7,010 | 6,602 | 7,261 | 9,236 |
| Operating Income | -5,339 | -6,792 | -6,193 | -6,930 | -8,889 |
| Interest Expense | 975 | 975 | 975 | 975 | 975 |
| Other Income | 47 | 87 | 223 | 235 | 442 |
| Pre-tax Income | -6,267 | -7,680 | -6,945 | -7,670 | -9,422 |
| Net Income Continuous | -6,267 | -7,680 | -6,945 | -7,670 | -9,422 |
| Net Income Discontinuous | -153 | -4,324 | -147 | -128 | -319 |
| Minority Interests | -22 | -39 | N/A | N/A | N/A |
| Net Income | $-6,398 | $-11,965 | $-7,092 | $-7,799 | $-9,741 |
| EPS Basic Total Ops | -63.76 | -120.01 | -60.01 | -86.26 | -120.01 |
| EPS Basic Continuous Ops | -63.76 | -76.52 | -58.36 | -86.26 | -116.32 |
| EPS Basic Discontinuous Ops | -1.53 | -43.08 | 0.10 | -1.42 | -3.94 |
| EPS Diluted Total Ops | -63.76 | -120.01 | -60.01 | -86.26 | -120.01 |
| EPS Diluted Continuous Ops | -63.76 | -76.52 | -58.36 | -86.26 | -116.32 |
| EPS Diluted Discontinuous Ops | -1.53 | -43.08 | 0.10 | -1.42 | -3.94 |
| EBITDA(a) | $-4,800 | $-6,237 | $-5,628 | $-6,375 | $-8,322 |